Clinical Trials Arena July 30, 2024
Following the release of the FDA’s guidance, sponsors must now specify their rationale and goals for clinical study enrolment.
Clinical trial diversity remained a hot topic throughout Clinical Trial Arena’s global Outsourcing in Clinical Trial (OCT) Conference series at the beginning of 2024.
Critical conversations were at an all-time high during the 11th Annual Outsourcing in Clinical Trials UK & Ireland conference, held on 11-12 June 2024, two weeks before the US Food and Drug Administration (FDA) was set to issue its long-awaited Diversity Action Plan.
During the conference, the lack of transparency around key clinical trials and diversity metrics became a massive talking point.
During a well-attended panel discussion, Andrew Ustianowski, network director for Upcoming Northwest Regional Research Diversity...
Today's Sponsors
Today's Sponsor